Merck & Co Inc (LSE:0QAH)
$ 100 0 (0%) Market Cap: 252.20 Bil Enterprise Value: 275.80 Bil PE Ratio: 20.90 PB Ratio: 5.67 GF Score: 87/100

Q2 2020 Merck & Co Inc Earnings Call Transcript

Jul 31, 2020 / 12:00PM GMT
Release Date Price: $77.84 (+2.81%)
Operator

Good morning. My name is Lara, and I will be your conference operator today. At this time, I would like to welcome everyone to the Merck & Co. Q2 Sales and Earnings Conference Call. (Operator Instructions) Thank you.

I would now like to turn the call over to Peter Dannenbaum, Vice President of Investor Relations. Please go ahead.

Peter Dannenbaum
Merck & Co., Inc. - VP of IR

Thank you, Lara, and good morning. Welcome to Merck's Second Quarter 2020 Conference Call. Today, I'm joined by Ken Frazier, our Chairman and Chief Executive Officer; Rob Davis, our Chief Financial Officer; Dr. Roger Perlmutter, President of Merck Research Labs; Frank Clyburn, our Chief Commercial Officer; and Mike Nally, our Chief Marketing Officer.

Before we get started, I'd like to point out a few items. You will see that we have items in our GAAP results such as acquisition-related charges, restructuring costs and certain [other items. You should note] that we have excluded these from our non-GAAP results and provide a reconciliation in our press release. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot